We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment of buccal mucosal carcinomas: A survey amongst head and neck surgeons in the Netherlands.
- Authors
Adriaansens, Carleen M. E. M.; Noorlag, Rob; de Bree, Remco; van Es, Robert J. J.
- Abstract
Objective: Currently, there is no up‐to‐date guideline for the treatment of buccal mucosal squamous cell carcinoma (BMSCC) in the Netherlands. A questionnaire was used to investigate the opinions of Dutch head and neck surgeons on BMSCC of the cheek treatment. Methods: A questionnaire was sent to all 91 head and neck surgeons in the Netherlands. Their opinions on surgical tumor‐free margins, through‐and‐through defects, and indications for local adjuvant therapy were questioned. Results: The response rate was 51%. To prevent a through‐and‐through defect, 67% of the surgeons would accept a deep clinical (macroscopic) margin of ≤5 mm. The less adverse histological characteristics a tumor has, the less consensus there is amongst the surgeons for local adjuvant treatment in case of close margins. Conclusion: There is no consensus amongst Dutch head and neck surgeons about the optimal treatment for BMSCC of the cheek. There are different opinions on acceptable resection margins, indications for a through‐and‐through defect, and indications for adjuvant treatment. BMSCC of the cheek treatment should be more uniform and less surgeon dependent. Level of evidence: N/A
- Subjects
NETHERLANDS; SURGEONS; SQUAMOUS cell carcinoma; CARCINOMA; SURGICAL margin; HEAD
- Publication
Laryngoscope Investigative Otolaryngology, 2023, Vol 8, Issue 4, p857
- ISSN
2378-8038
- Publication type
Article
- DOI
10.1002/lio2.1081